Salmeterol
Serevent, BroPair Spiromax, Seffalair Spiromax (salmeterol) is a small molecule pharmaceutical. Salmeterol was first approved as Serevent on 1994-02-04. It is used to treat asthma and bronchial spasm in the USA. It has been approved in Europe to treat asthma. The pharmaceutical is active against beta-2 adrenergic receptor.
| Trade Name | BroPair Spiromax, Seffalair Spiromax |
|---|---|
| Common Name | Salmeterol |
| Indication | asthma, bronchial spasm |
| Drug Class | Bronchodilators (phenethylamine derivatives); anti-inflammatory agents (salicylic acid derivatives) |
